Amphastar Pharmaceuticals, Inc.
AMPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001297184
In the last 90 days, Amphastar Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 212 institutions reported holding it in 13F filings for Q2 2026, worth $572.1M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Amphastar Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 135 | 146 | +11 |
| Shares | 26.0M | 27.3M | +1.23M (+4.7%) |
| Value | $476.9M | $549.6M | +$72.7M (+15.2%) |
New holders (28)
Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (17)
Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| State of New Jersey Common Pension Fund D | 127,622 | $2.34M |
| Mackay Shields LLC | 101,200 | $1.85M |
| Two Sigma Investments, LP | 88,375 | $1.62M |
| California Public Employees Retirement System | 74,100 | $1.36M |
| Skandinaviska Enskilda Banken AB (publ) | 36,800 | $674.0K |
| Gsa Capital Partners LLP | 34,425 | $631.0K |
| Pictet Asset Management Ltd | 33,839 | $620.0K |
| First Trust Advisors LP | 31,416 | $584.0K |
| Ergoteles LLC | 15,543 | $285.0K |
| Susquehanna International Group, LLP | 14,574 | $267.0K |
| Trexquant Investment LP | 12,503 | $229.0K |
| Campbell & CO Investment Adviser LLC | 11,961 | $219.0K |
| SG Americas Securities, LLC | 5,487 | $101.0K |
| Quantbot Technologies LP | 2,900 | $53.0K |
| Tarbox Family Office, Inc. | 123 | $2.00K |
| Wealthcare Advisory Partners LLC | 60 | $1.00K |
| Meridian Wealth Partners, LLC | 8 | $0 |